Skip to content
Disclosery

CAXTON ASSOCIATES LP: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CAXTON ASSOCIATES LP on GMED, newest first. How the timeline and the estimate are built.

CAXTON ASSOCIATES LP held 0 GMED shares at 2023-09-30 per its 13F-HR filed 2023-11-14.

the latest 13F is the newest step

  1. period ended2023-09-30
    13F 0 shares
    Change vs previous 13F -18,501 shares

    13F-HR 0000872573-23-000011 filed by CAXTON ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2023-06-30
    13F 18,501 shares
    Change vs previous 13F -23,089 shares

    0.16% of the 13F portfolio, value $1,101,550.

    13F-HR 0000872573-23-000009 filed by CAXTON ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2023-03-31
    13F 41,590 shares
    Change vs previous 13F not available

    0.37% of the 13F portfolio, value $2,355,658.

    13F-HR 0000899140-23-000644 filed by CAXTON ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).